Département d'Anesthésiologie, Centre hospitalier de l'Université de Montréal, Montreal, QC, H2L 4M1, Canada.
Département de Biochimie, Centre hospitalier de l'Université de Montréal, Montreal, QC, Canada.
Can J Anaesth. 2022 Sep;69(9):1151-1159. doi: 10.1007/s12630-022-02260-x. Epub 2022 May 5.
Erector spinae plane blocks (ESPB) and pectointercostal fascial (PIFB) plane blocks are novel interfascial blocks for which local anesthetic (LA) doses and concentrations necessary to achieve safe and effective analgesia are unknown. The goal of this prospective observational study was to provide the timing (T) and concentration (C) of maximum total and free plasma bupivacaine after ESPB in breast surgery and after PIFB in cardiac surgery patients.
Erector spinae plane blocks or PIFBs (18 patients per block; total, 36 patients) were performed with 2 mg⋅kg of bupivacaine with epinephrine 5 μg⋅mL. Our principal outcomes were the mean or median C of total and free plasma bupivacaine measured 10, 20, 30, 45, 60, 90, 180, and 240 min after LA injection using liquid chromatography with tandem mass spectrometry.
For ESPB, the mean (standard deviation [SD]) total bupivacaine C was 0.37 (0.12) μg⋅mL (range, 0.19 to 0.64), and the median [interquartile range (IQR)] T was 30 [50] min (range, 10-180). For ESPB, the mean (SD) free bupivacaine C was 0.015 (0.017) μg⋅mL (range, 0.003-0.067), and the median [IQR] T was 30 [20] min (range, 10-120). After PIFB, mean plasma concentrations plateaued at 60-240 min. For PIFB, the mean (SD) total bupivacaine C was 0.32 (0.21) μg⋅mL (range, 0.14-0.95), with a median [IQR] T of 120 [150] min (range, 30-240). For PIFB, the mean (SD) free bupivacaine C was 0.019 (0.010) μg⋅mL (range, 0.005-0.048), and the median [IQR] T was 180 [120] min (range, 30-240). For both ESPB and PIFB, we observed no correlations between pharmacokinetic and demographic parameters.
Total and free bupivacaine C observed after ESPB and PIFB with 2 mg⋅kg of bupivacaine with epinephrine 5 μg⋅mL were five to twenty times lower than levels considered toxic in the literature.
竖脊肌平面阻滞(ESPB)和胸膜肋间筋膜平面阻滞(PIFB)是两种新的筋膜间阻滞技术,其达到安全有效镇痛所需的局部麻醉药(LA)剂量和浓度尚不清楚。本前瞻性观察性研究的目的是提供在乳腺手术中进行 ESPB 后和心脏手术中进行 PIFB 后,布比卡因总血浆和游离血浆浓度达到峰值的时间(T)和浓度(C)。
使用含有肾上腺素 5 μg·mL 的 2 mg·kg 的布比卡因进行 ESPB 或 PIFB(每组阻滞 18 例患者,共 36 例患者)。我们的主要结局是使用液相色谱-串联质谱法测量 LA 注射后 10、20、30、45、60、90、180 和 240 分钟时,总血浆和游离布比卡因的平均或中位数 C。
对于 ESPB,布比卡因总 C 的均值(标准差 [SD])为 0.37(0.12)μg·mL(范围,0.19-0.64),中位数 [四分位间距(IQR)] T 为 30 [50] min(范围,10-180)。对于 ESPB,布比卡因游离 C 的均值(SD)为 0.015(0.017)μg·mL(范围,0.003-0.067),中位数 [IQR] T 为 30 [20] min(范围,10-120)。PIFB 后,血浆浓度在 60-240 分钟时达到平台期。对于 PIFB,布比卡因总 C 的均值(SD)为 0.32(0.21)μg·mL(范围,0.14-0.95),中位数 [IQR] T 为 120 [150] min(范围,30-240)。对于 PIFB,布比卡因游离 C 的均值(SD)为 0.019(0.010)μg·mL(范围,0.005-0.048),中位数 [IQR] T 为 180 [120] min(范围,30-240)。对于 ESPB 和 PIFB,我们未观察到药代动力学和人口统计学参数之间存在相关性。
ESPB 和 PIFB 中使用 2 mg·kg 的布比卡因加肾上腺素 5 μg·mL 后,总血浆和游离布比卡因 C 分别为文献中认为毒性的五至二十倍。